欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/2242/001
药品名称
Utrogestan
活性成分
Progesterone 300.0 mg
剂型
Vaginal capsule, soft
上市许可持有人
Besins Healthcare Ireland Ltd. IRELAND
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Malta (MT)
Luxembourg (LU)
Iceland (IS)
Ireland (IE)
France (FR)
Spain (ES)
Norway (NO)
Utrogestan
Portugal (PT)
Latvia (LV)
Progesterone Besins 300 mg mīkstās vaginālās kapsulas
Italy (IT)
Estonia (EE)
UTROGESTAN
Poland (PL)
Utrogestan
Hungary (HU)
UTROGESTAN 300 mg lágy hüvelykapszula
Lithuania (LT)
Progesterone Besins 300 mg makšties minkštosios kapsulės
Bulgaria (BG)
Utrogestan
Cyprus (CY)
Utrogestan Κολπικό 300 mg καψάκιο, μαλακό
Slovakia (SK)
Czechia (CZ)
Utrogestan
Finland (FI)
Lugesteron
Belgium (BE)
Utrogestan Vaginal 300 mg capsules molles
Slovenia (SI)
Netherlands (NL)
Croatia (HR)
Utrogestan 300 mg meke kapsule za rodnicu
Denmark (DK)
Progestan
许可日期
2021/04/07
最近更新日期
2025/01/20
药物ATC编码
G03DA04 progesterone
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
PubAR
|
https___www_lakemedelsverket_se_sv_sok_lakemedelsfakta_lakemedel_id_20200722000041
Date of last change:2024/09/06
PubAR Summary
|
https___www_lakemedelsverket_se_sv_sok_lakemedelsfakta_lakemedel_id_20200722000041_2
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase